Job Title: Junior Clinical Research Associate (JCRA)
Department: Clinical Operations, Research & Development, (CDC South Africa)
Location: Johannesburg, South Africa. Travel to clinical trial sites is required.
As Junior Clinical Research Associate, you will be the link between Novo and the clinical trial sites where our studies happen. You will monitor how trials run in real life, protect the safety and rights of the people taking part, and make sure the data collected can be trusted. Your work keeps studies on track, on time and in line with ICH-GCP, so promising science can move forward with the quality people deserve.
You already know how industry-sponsored clinical research works and are ready to take ownership of your own sites. You will bring:
You will oversee your assigned sites from day to day, combining on-site and remote monitoring with risk-based quality management (RBQM) – focusing your attention where the risks to quality and safety are greatest.
In Research & Development, colleagues explore scientific ideas and advance them towards clinical testing. As part of Clinical Operations, you will help turn that work into well-run trials at sites in South Africa.
Your closest partners will be investigators, study nurses and coordinators at your sites. Inside Novo, you will work alongside Trial Managers, the Study Start-up team, Clinical Trial Administrators, payment specialists and fellow CRAs, and connect with trial squads and Global Project Teams. You may also engage with ethics committees, local health authorities and vendors.
You will report to Neo Nkonyane, Clinical Operations Manager and take part in investigator meetings, CRA training sessions and trial meetings, locally and globally. These relationships help you get clarity quickly, solve issues together and keep studies moving.
This is a role where you can grow your monitoring expertise on the job. You will take responsibility for your own sites while learning from experienced CRAs, your manager and the wider trial team, and build new skills through CRA training and international study meetings.
Your voice matters here. You are encouraged to speak up early, share what you see at site level and suggest simple improvements – because better ways of working lead to better trials for the people taking part in them.
Your impact begins today. If you are ready to help bring high-quality clinical trials to life, apply for the Junior Clinical Research Associate (JCRA) role by 19 October 2026.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.
Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html